Engin Ozkan to Neoplasms
This is a "connection" page, showing publications Engin Ozkan has written about Neoplasms.
Connection Strength
0.130
-
"Velcro" engineering of high affinity CD47 ectodomain as signal regulatory protein a (SIRPa) antagonists that enhance antibody-dependent cellular phagocytosis. J Biol Chem. 2015 May 15; 290(20):12650-63.
Score: 0.090
-
Engineered SIRPa variants as immunotherapeutic adjuvants to anticancer antibodies. Science. 2013 Jul 05; 341(6141):88-91.
Score: 0.040